[Federal Register Volume 63, Number 111 (Wednesday, June 10, 1998)]
[Rules and Regulations]
[Pages 31623-31624]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-15481]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 510
Animal Drugs, Feeds, and Related Products; Change of Sponsor Name
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect a change of sponsor name from Boehringer
Ingelheim Animal Health, Inc., to Boehringer Ingelheim Vetmedica, Inc.
EFFECTIVE DATE: June 10, 1998.
FOR FURTHER INFORMATION CONTACT: Thomas J. McKay, Center for Veterinary
Medicine (HFV-102), Food and Drug
[[Page 31624]]
Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-0213.
SUPPLEMENTARY INFORMATION: Boehringer Ingelheim Animal Health, Inc.,
2621 North Belt Hwy., St. Joseph, MO 65406, has informed FDA of a
change of sponsor name to Boehringer Ingelheim Vetmedica, Inc.
Accordingly, the agency is amending 21 CFR 510.600(c)(1) and (c)(2) to
reflect the change of sponsor name.
List of Subjects in 21 CFR Part 510
Administrative practice and procedure, Animal drugs, Labeling,
Reporting and recordkeeping requirements.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is
amended as follows:
PART 510--NEW ANIMAL DRUGS
1. The authority citation for 21 CFR part 510 continues to read as
follows:
Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.
Sec. 510.600 [Amended]
2. Section 510.600 Names, addresses, and drug labeler codes of
sponsors of approved applications is amended in the table in paragraph
(c)(1) by removing the entry for ``Boehringer Ingelheim Animal Health,
Inc.'' and by alphabetically adding a new entry for ``Boehringer
Ingelheim Vetmedica, Inc.''; and in the table in paragraph (c)(2) in
the entry for ``000010'' by removing the sponsor name ``Boehringer
Ingelheim Animal Health, Inc.'' and adding in its place ``Boehringer
Ingelheim Vetmedica, Inc.''
Dated: May 22, 1998.
Andrew J. Beaulieu,
Acting Director, Office of New Animal Drug Evaluation, Center for
Veterinary Medicine.
[FR Doc. 98-15481 Filed 6-9-98; 8:45 am]
BILLING CODE 4160-01-F
